ChemoCentryx Inc (NASDAQ:CCXI)

8.00
Delayed Data
As of Jul 02
 +0.10 / +1.27%
Today’s Change
4.06
Today|||52-Week Range
9.46
+17.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$349.6M

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:

Employees

Shareholders

Individual stakeholders48.77%
Other institutional35.25%
Mutual fund holders23.83%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
Susan M. KanayaCFO, Secretary & Head-Investor Relations
Petrus BekkerChief Medical Officer
Israel CharoSenior Vice President-Research
Markus J. CappelTreasurer & Chief Business Officer

To view my watchlist

Not a member yet?

Sign up now for a free account